Including intravenous immunoglobulin (IVIG) as part of routine care may help to ease muscle, skin, and digestive symptoms in…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Boehringer Ingelheim has joined the CONQUEST platform trial, adding a second experimental medication to the multidrug study launched…
A prediction tool known as nomogram may be used to calculate the chance of a person with systemic sclerosis…
A noninvasive form of vagus nerve stimulation therapy may help safely reduce pain in people with systemic sclerosis (SSc),…
The European Patent Office has decided to grant MediciNova a patent covering the use of an investigational small molecule called…
Sanofi will be the first company to join CONQUEST, a new platform trial launched by the Scleroderma Research…
Seven genes were identified as potential drivers of systemic sclerosis (SSc) in a bioinformatics study, and may offer opportunities…
A type of cell death called ferroptosis and the genes related to it may play a role in systemic…
A protein called GRB2 is found in higher levels in cells lining the skin’s blood vessels of people with…
The European Commission (EC) has given orphan drug designation to efzofitimod as a potential treatment of systemic sclerosis, also…